OMCL
Omnicell, Inc.
Health Information Services · Healthcare · United States
37.64
close · 2026-08-13
value
73
cheaper than peers73
quality
71
stronger fundamentals71
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.33× | 90 |
| price to sales | 1.29× | 81 |
| forward P/E | 18.01× | 53 |
| EV to EBITDA | 16.52× | 49 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 10.4% | 71 |
| return on equity | 3.1% | 65 |
| debt to equity | 14.6% | 65 |
| revenue growth | 7.5% | 42 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $154.0M |
| employees | 3,580 |
| first trade | 2001-08-09 |
| next earnings | 2026-07-30 |
| fundamentals updated | 2026-07-31 |